Hudson Executive Capital LP
Long book
$150.9M
Q1 2026
Positions
2
Top-10 weight
100%
concentration
Last quarter
+0.5%
SPY +14.8%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsHudson Executive Capital LP is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $150.9M US long book across 2 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: CANTALOUPE INC, TALKSPACE INC.
Over the last 9 quarters its long book ran on average 3.1pp per quarter ahead of the S&P 500, beating the index in 3 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-35.6%
Q2 2024
-9.1%
Q3 2024
+47.8%
Q4 2024
-17.2%
Q1 2025
+8.6%
Q2 2025
-0.7%
Q3 2025
+31.5%
Q4 2025
+42.6%
Q1 2026
+0.5%
Sector allocation
Other 66%
Healthcare 34%
Long book by quarter
What does Hudson Executive own?
Q1 2026 13F13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 2 | $150.9M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 2 | $134.0M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 2 | $125.0M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 3 | $135.0M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 3 | $103.9M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 4 | $392.0M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 4 | $391.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 4 | $366.6M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 4 | $395.1M | canonical | SEC ↗ |